Solving Kids’ Cancer UK Sitemap
- Neuroblastoma
- Find support
- Third party events terms and conditions
- Research
-
Get involved
- Appeals and events
- Named funds
- Fundraising hub
- Campaign for children with cancer
- Volunteering
- Event Volunteering
- Ways you can give
- Challenge events
- Corporate partnerships
- Leave a gift in your Will
- About neuroblastoma
- Newly diagnosed
- Low-risk neuroblastoma
- Intermediate-risk neuroblastoma
- High-risk neuroblastoma
- Refractory neuroblastoma
- Relapsed neuroblastoma
- Clinical trials for neuroblastoma
- Financial support
- Post-treatment support
- Bereavement support
- Treatment for neuroblastoma
-
Services
- Personalised Family Support
- Family Support Bags
- Neuroblastoma Parent Symposium
- Family Fun Day
- Named Funds
- Support accessing treatment not available on the NHS
- Fundraising for treatment not available through the NHS
- Wellbeing grants
- Big Love Fund bereavement grants
- Post‑treatment Coaching Programme
- Connected After Cancer: Peer-to-peer drop-ins
- Bereavement Coaching Programme
- Contact Family Support
-
Resources
- Coping with diagnosis
- Treating high-risk neuroblastoma in 2022: Where are we now?
- Neuroblastoma basics: Introduction to neuroblastoma
- Dealing with a childhood cancer diagnosis
- Coping as a family and accessing support services
- Low and intermediate-risk neuroblastoma
- Neuroblastoma landscape overview
- Treating high-risk neuroblastoma: Where are we now?
- The challenge of curing high-risk neuroblastoma
- Treating relapsed and refractory neuroblastoma
- Treating relapsed and refractory disease: CAR T-cell therapy
- CAR T-cell therapies: Where are we now
- If treatment doesn't go to plan
- CAR T-cells in the clinic
- COG/NANT relapse strategy and trials
- Hope in survivorship
- Understanding treatment-related late effects
- Post treatment: A parent's perspective
- The importance of aftercare/long term follow up
- Post-traumatic stress and PTSD in paediatric cancer survivors and parents
- Transitioning into adulthood
- Pain and pain management
- Neuroblastoma has shaped but not defined me
- Life after treatment: Enhancing quality of life for neuroblastoma families
- Challenges after treatment and adult survivor stories
- The MINT Study: Addressing unmet need in high-risk neuroblastoma
- Finding trusted information: Navigating the neuroblastoma journey
- BEACON2: Expanding treatment options for relapsed neuroblastoma
- CAR T-cell therapy: Bambino Gesù trial and broadening treatment in Europe
- National Neuroblastoma Advisory Panel
- Psychosocial Cancer Toolbox: Understanding and managing fatigue
- Psychosocial Cancer Toolbox: PTSD and anxiety
- Psychosocial Cancer Toolbox: Post-traumatic growth
- Psychosocial Cancer Toolbox: Understanding and addressing paediatric medical trauma
- Psychosocial cancer toolbox: Putting the pieces back together
- Messages of hope
- The importance of hope
- Anti-GD2 antibody therapy
- Advances in immunotherapy
- What is neuroblastoma?
- Post-maintenance therapies
- Understanding Current Frontline Treatment: COG and SIOPEN
-
Articles
- How is neuroblastoma diagnosed?
- What are ALK mutations in neuroblastoma?
- What are the survival rates for high-risk neuroblastoma?
- What are the survival rates for intermediate‑risk neuroblastoma?
- What are the survival rates for low‑risk neuroblastoma?
- What are the symptoms of neuroblastoma?
- What causes neuroblastoma?
- What do the different risk groups for neuroblastoma mean?
- What do the different stages of neuroblastoma mean?
- What does it mean if my child has MYCN amplification?
- What is high-risk neuroblastoma?
- What is intermediate-risk neuroblastoma?
- What is low‑risk neuroblastoma?
- What is neuroblastoma?
- Where does neuroblastoma occur?
- Who is affected by neuroblastoma?
- How can I fundraise for neuroblastoma treatment outside of the NHS?
- Should I be fundraising for additional treatment for neuroblastoma?
- How can I get support to access treatment not available on the NHS?
- Can I change my mind about enrolling my child on a clinical trial?
- Should I enrol my child on a clinical trial for neuroblastoma?
- What is a clinical trial?
- Are we still eligible for financial support post treatment?
- Is there support available for travel costs during treatment?
- What financial support can I get after my child has been diagnosed with neuroblastoma?
- Are there clinical trials for refractory neuroblastoma?
- What are the survival rates for refractory neuroblastoma?
- What does refractory disease mean?
- What is the treatment for refractory neuroblastoma?
- Are there clinical trials available for relapsed neuroblastoma?
- What are the survival rates for relapsed neuroblastoma?
- What does it mean when my child has relapsed neuroblastoma?
- What is the treatment for relapsed neuroblastoma?
- How do I refer my child to the National Neuroblastoma Advisory Panel?
- What is the National Neuroblastoma Advisory Panel?
- Can I get a second opinion about my child’s diagnosis or treatment plan?
- Should I tell my consultant that I want a second opinion?
- Are there neuroblastoma parent support groups?
- Can I get access to counselling?
- Can my child get access to counselling?
- Can you connect me to other families in my situation?
- How can we cope with neuroblastoma as a family?
- Where can I find support post‑treatment?
- How quickly should my child start treatment after diagnosis?
- Is it right that my child doesn’t need treatment for low‑risk neuroblastoma?
- What are the immediate side effects of induction chemotherapy for neuroblastoma?
- What are the immediate side effects of high-dose chemotherapy for neuroblastoma?
- What are the immediate side effects of immunotherapy for neuroblastoma?
- What are the immediate side effects of radiotherapy for neuroblastoma?
- What are the immediate side effects of stem-cell transplant for neuroblastoma?
- What are the immediate side effects of surgery for neuroblastoma?
- What are the immediate side effects of neuroblastoma treatment?
- What follow-up care will my child need after treatment for neuroblastoma?
- What happens if my child doesn’t respond to frontline treatment?
- What if my child can’t have surgery for neuroblastoma?
- What is the best option for my child: photon radiotherapy or proton beam therapy?
- What is the treatment for high-risk neuroblastoma?
- What is the treatment for intermediate‑risk neuroblastoma?
- What is the treatment for low‑risk neuroblastoma?
- What support is there to help me make treatment decisions?
- Should I randomise for tandem transplant in the High‑Risk Neuroblastoma 2 trial?
- What is the SIOPEN High‑Risk Neuroblastoma 2 (HR‑NBL2) Trial?
- What support can I get for my child with neuroblastoma?
- Where can I find support in my region after my child has been diagnosed with cancer?
- What is DFMO therapy for neuroblastoma?
- What is the bivalent vaccine for neuroblastoma?